Back to Search
Start Over
Response to 'Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis’'
- Source :
- Dermatology and Therapy, Vol 14, Iss 3, Pp 823-827 (2024)
- Publication Year :
- 2024
- Publisher :
- Adis, Springer Healthcare, 2024.
- Subjects :
- Dermatology
RL1-803
Subjects
Details
- Language :
- English
- ISSN :
- 21938210 and 21909172
- Volume :
- 14
- Issue :
- 3
- Database :
- Directory of Open Access Journals
- Journal :
- Dermatology and Therapy
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.0daa9fbf55ac40f68df2168ef81d0a72
- Document Type :
- article
- Full Text :
- https://doi.org/10.1007/s13555-024-01107-1